Most of the articles on this subject deliberately overlook a few things:
1. The drug in question has been in production for more than 60 years. There's no patent protection and no proprietary limitations on it. In other words, anyone who wants to produce a generic knock-off can do so freely.
2. One reason why nobody wants to produce generic alternatives to this drug is that it is only used by about 10,000 patients right now. And these patients are typically people with compromised immune systems ... basically, AIDS patients. Would this story get all this attention if it involved another type of user?
I would imagine that if the bozo had not rolled back the price. Trump would have bout a pharma manufacturer, and produced the generic, and sold it at half the price of the original price, and still made a profit. That is the Trump way...LOL
I would imagine that if the bozo had not rolled back the price. Trump would have bought a pharma manufacturer, and produced the generic, and sold it at half the price of the original price, and still made a profit. That is the Trump way...LOL
The FDA requires a passel of inspections and paperwork that cannot be recouped on a small amount of revenue. It does help keep the supply safe, even for imports, but it is very onerous.
Nobody pays list.